WebMIAMI, Mar 31, 2004 /PRNewswire-FirstCall via COMTEX/ -- Cordis Corporation, a Johnson & Johnson company, reported today it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its … http://www.mrisafety.com/TMDL_list.php?goto=53
CYPHER® Sirolimus-eluting Coronary Stent bene EurekAlert!
http://www.ptca.org/pr_jnj/20060426.html http://www.ptca.org/pr_jnj/20051014.html harjun koulu
Home - Cypher-LLC
WebRepresenting a best-in-class radial offering from Cordis, the Radianz Radial Peripheral System™ is purposely engineered to deliver exceptional outcomes and a high level of … Santa Clara Office 5452 Betsy Ross Dr. Santa Clara, CA 95054. 408.273.3700 Shar Matin Chief Executive Officer CEO Shar Matin is ushering in a bold new era … Your questions are important to us, call our Customer Service at 800.327.7714 Product Description. For use in arterial and venous procedures requiring … 1 Compared to conventional radial sheaths. Profile reduction is 1.2F compared to … Proprietary KINK RECOVERY TECHNOLOGY. Elastomeric properties … EMERALD ™ Diagnostic Guidewire Intended for percutaneous entry and … INFINITI ® Diagnostic Catheter The Cordis INFINITI 4F, 5F and 6F line of … Product Description. AQUATRACK Guidewires offer: Superior torque: A … Customer Service and Ordering Information. In the United States, email … WebApr 20, 2005 · In clinical trials, the CYPHER (R) Stent has been shown to reduce reblockage in the arteries by more than 90 percent over a conventional bare metal stent. … WebFor additional information on the CYPHER Stent, visit www.CYPHERUSA.com or call 1-800-781-0282. * Cordis has entered into an exclusive worldwide license with Wyeth for the localized delivery of sirolimus in certain fields of use, including. delivery via vascular stenting. Sirolimus, the active drug released harjun kirppis